EyePoint, Zions, GE Aerospace Price Targets, October 20 2026

EyePoint

EyePoint is a clinical-stage drug developer based in Watertown, Massachusetts. It works on treatments for retinal disease, and its lead product is DURAVYU, a vorolanib insert placed inside the eye. The company has almost no sales yet. Second-quarter revenue was $0.51 million. The net loss came to $1.09 a share, wider than the $0.94 estimate.

On Monday, EyePoint said DURAVYU missed the primary goal of LUCIA, its second pivotal Phase 3 trial in wet age-related macular degeneration. The drug did not prove non-inferior to on-label aflibercept on vision scores. The company said it met key secondary goals. EyePoint is cutting about 53% of its staff. It is also ending both wet AMD trials early. It now plans to focus on DURAVYU in diabetic macular edema, with Phase 3 data expected in the fourth quarter of 2027. The company put annual savings at about $30 million.

Five Desks Act on EyePoint

Tessa Romero of JPMorgan cut EyePoint to Underweight from Neutral today, a Tuesday. Graig Suvannavejh of Mizuho downgraded the stock to Neutral from Outperform. Lisa Walter of RBC Capital kept Sector Perform and took her target from $5 to $1. Yi Chen of HC Wainwright reiterated Neutral. Yale Jen of Laidlaw downgraded the stock to Hold from Buy.

Two downgrades came on Monday, the day of the readout. Kambiz Yazdi of Jefferies moved to Hold from Buy. Yatin Suneja of Guggenheim went to Neutral.

Several of these desks had already cut in August. Walter cut her rating to Sector Perform and her target from $37 to $5 on August 18. Romero moved from Overweight to Neutral on August 17, and Yazdi cut his target from $30 to $8 the same day.

EyePoint’s Record on AnaChart

EyePoint draws 9 covering analysts on AnaChart. Their average target is $29.77, a figure that predates both the August cuts still on file and this week’s notes. The high is $68 and the low is $5. AnaChart’s tracking shows only 22.91% of EyePoint targets get met, after about 214 days on average. Chen has met 8 of his 20 targets on the stock, with an average potential upside of 110.44%.

Zions Bancorp

Zions Bancorporation is a Salt Lake City bank with about $89 billion in assets at the end of 2025. It runs seven separately managed bank divisions across the western states, including Zions Bank, Amegy Bank in Texas and California Bank & Trust. Most of its income comes from the spread between loan and deposit rates. Net earnings for the third quarter came to $262 million.

Zions reported third-quarter results after Monday’s close. Earnings came to $1.78 a share, against a $1.66 consensus. Revenue was $881 million, just under the $889.98 million estimate. A year earlier it earned $1.48 a share on $872 million. The bank has beaten the EPS consensus in each of the last six quarters.

Jefferies and Citi Trim, Baird and DA Davidson Raise on Zions

David Chiaverini of Jefferies lowered his target from $80 to $75 today, a Tuesday. Ben Gerlinger of Citi kept Neutral and cut his from $73 to $70. David George of Baird went the other way and lifted his target from $75 to $80, with an Outperform rating. Peter Winter of DA Davidson raised his from $79 to $80.

George had upgraded Zions to Outperform from Neutral on October 15, a Thursday. Dave Rochester of Cantor Fitzgerald trimmed his target to $76 on October 14.

Zions Bancorp’s Record on AnaChart

Zions draws 23 covering analysts on AnaChart. Their average target is $67.57, with a high of $84 and a low of $57. Ratings split 23.19% Buy, 66.67% Hold and 10.14% Sell. AnaChart’s tracking shows 91.56% of Zions targets get met, after about 455 days on average. George has met 25 of his 27 targets on the stock, with an average potential upside of 19.03%.

GE Aerospace

GE Aerospace builds jet engines and sells the parts and services that keep them flying. Revenue over the last four reported quarters came to about $49 billion. Through CFM International, its venture with Safran, it supplies engines for narrowbody jets. Parts and services make up more than 70% of its commercial engine revenue.

The company reported third-quarter results before the open today. Adjusted earnings were $2.25 a share, against a $2.00 consensus. Revenue reached $13.29 billion, above the $12.85 billion estimate. A year earlier the quarter brought $1.66 a share on $11.31 billion. The commercial engines and services unit brought in $10.34 billion, 21% more than a year earlier. GE Aerospace raised its 2026 adjusted EPS forecast to $8.00 to $8.10, from $7.65 to $7.85. Chief executive Larry Culp said the commercial services backlog is above $170 billion.

Jefferies Backs GE Aerospace After the Beat

Sheila Kahyaoglu of Jefferies reiterated Buy with a $435 target this morning, a Tuesday. She had cut that target from $455 to $435 on September 23. David Strauss of Wells Fargo set his target at $380 on September 30.

GE Aerospace’s Record on AnaChart

GE Aerospace draws 14 covering analysts on AnaChart. Their average target is $382.18. The high is $450 and the low is $301. Ratings split 97.96% Buy and 2.04% Hold. AnaChart’s tracking shows 85.87% of GE targets get met, after about 529 days on average. Kahyaoglu has met 10 of her 12 targets on the stock, with an average potential upside of 36.02%.

What the Performance Matrix Shows

Zions has the best met ratio of the three and EyePoint the lowest. The waits run the other way. An EyePoint target that gets met lands in about 214 days, while a GE target takes close to a year and a half. AnaChart’s first GE forecast dates to March 2006, its first Zions forecast to June 2012 and its first EyePoint forecast to May 2017.

AnaChart tracks every price target against what happened to the stock afterward, desk by desk and analyst by analyst. The ticker pages linked above break out each record by analyst, firm and year. AnaChart’s full data set holds more than 760,000 analyst calls on more than 9,000 tickers, active and delisted. More than 680,000 carry a price target and more than 730,000 carry a rating. It is the second largest database of its kind. The raw file is available through the AnaChart store.

The previous update covered Boyd Gaming, Intel and Dow on October 19.

Top analyst price target moves on AnaChart, October 20 2026
Top analyst price target moves on AnaChart.com, October 20 2026